UBS Group’s Alerian MLP ETF AMLP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-10,800
Closed -$411K 9554
2022
Q4
$411K Hold
10,800
﹤0.01% 4862
2022
Q3
$395K Hold
10,800
﹤0.01% 4543
2022
Q2
$372K Hold
10,800
﹤0.01% 4487
2022
Q1
$414K Buy
+10,800
New +$397K ﹤0.01% 4818
2021
Q3
Sell
-2,818,000
Closed -$103M 9489
2021
Q2
$103M Buy
2,818,000
+1,796,900
+176% +$61.7M 0.03% 510
2021
Q1
$31.1M Buy
+1,021,100
New +$29.8M 0.01% 1139
2016
Q1
Sell
-80
Closed -$5K 7601
2015
Q4
$5K Sell
80
-1,500
-95% -$93.9K ﹤0.01% 7676
2015
Q3
$99K Sell
1,580
-1,500
-49% -$109K ﹤0.01% 5244
2015
Q2
$240K Buy
3,080
+3,000
+3,750% +$250K ﹤0.01% 4717
2015
Q1
$7K Sell
80
-900
-92% -$76K ﹤0.01% 7884
2014
Q4
$86K Buy
+980
New +$88.8K ﹤0.01% 5854

Other funds holding AMLP

UBS Group's AMLP Position: Q1 2026 in Review

UBS Group increased its Alerian MLP ETF (AMLP) stake by 3.7% in Q1 2026, buying an estimated $5.76M and bringing the position to 3,195,287 shares worth $168M. The position accounts for 0.03% of the portfolio, ranked #702.

UBS Group first reported a position in AMLP in Q4 2014 and has held it in 46 quarters since. The position peaked at $319M in Q1 2017. 811 funds tracked by Wall St. Rank hold AMLP as of Q1 2026.

  • UBS Group held 3,195,287 shares of Alerian MLP ETF worth $168M as of Q1 2026.
  • UBS Group bought 113,129 Alerian MLP ETF shares in Q1 2026, an estimated $5.76M.
  • Alerian MLP ETF made up 0.03% of UBS Group's portfolio in Q1 2026, its #702 holding.
  • UBS Group first reported a position in Alerian MLP ETF in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Alerian MLP ETF position peaked at $319M in Q1 2017.
  • 811 funds tracked by Wall St. Rank held Alerian MLP ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.